From Wikipedia, the free encyclopedia
GSK2881078 structure.png
Legal status
Legal status
  • US: Investigational drug
  • 1-[(2R)-1-methylsulfonylpropan-2-yl]-4-(trifluoromethyl)indole-5-carbonitrile
CAS Number
PubChem CID
Chemical and physical data
Molar mass330.33 g·mol−1
3D model (JSmol)
  • C[C@H](CS(=O)(=O)C)N1C=CC2=C1C=CC(=C2C(F)(F)F)C#N
  • InChI=1S/C14H13F3N2O2S/c1-9(8-22(2,20)21)19-6-5-11-12(19)4-3-10(7-18)13(11)14(15,16)17/h3-6,9H,8H2,1-2H3/t9-/m1/s1

GSK2881078 is a drug which acts as a selective androgen receptor modulator (SARM). It was developed for the prevention of muscle wasting and sarcopenia in elderly people.[1][2][3]

See also[edit]


  1. ^ Clark RV, Walker AC, Andrews S, Turnbull P, Wald JA, Magee MH (October 2017). "Safety, pharmacokinetics and pharmacological effects of the selective androgen receptor modulator, GSK2881078, in healthy men and postmenopausal women". British Journal of Clinical Pharmacology. 83 (10): 2179–2194. doi:10.1111/bcp.13316. PMC 5595940. PMID 28449232.
  2. ^ Neil D, Clark RV, Magee M, Billiard J, Chan A, Xue Z, Russell A (September 2018). "GSK2881078, a SARM, Produces Dose-Dependent Increases in Lean Mass in Healthy Older Men and Women". The Journal of Clinical Endocrinology and Metabolism. 103 (9): 3215–3224. doi:10.1210/jc.2017-02644. PMID 29982690.
  3. ^ Zierau O, Kolodziejczyk A, Vollmer G, Machalz D, Wolber G, Thieme D, Keiler AM (May 2019). "Comparison of the three SARMs RAD-140, GLPG0492 and GSK-2881078 in two different in vitro bioassays, and in an in silico androgen receptor binding assay". The Journal of Steroid Biochemistry and Molecular Biology. 189: 81–86. doi:10.1016/j.jsbmb.2019.02.014. PMID 30825507. S2CID 72334106.

External links[edit]